Figures from the World Health Organization show [the proportion of counterfeits] can reach 35% of all [prescription] drugs in the Middle East, compared to less than 1% in the U.S. and Western Europe. One confiscated shipment by the Syrian ring to Egypt contained counterfeit copies of one brand of a leukemia drug [presumably Gleevec] with a street value of over $4 million -- equivalent to 50% of the annual sales of the brand.
…A great proportion of the fake drugs smuggled by the network to Egypt and Syria came from China…